Projects per year
Abstract
Non-invasive therapeutic ultrasound (US) methods, such as high-intensity focused ultrasound (HIFU), have limited access to tissue targets shadowed by bones or presence of gas. This study demonstrates that an ultrasonically actuated medical needle can be used to translate nanoparticles and fluids under the action of nonlinear phenomena, potentially overcoming some limitations of HIFU. A simulation study was first conducted to study the delivery of a tracer with an ultrasonically actuated needle (33 kHz) inside a porous medium acting as a model for soft tissue. The model was then validated experimentally in different concentrations of agarose gel showing a close match with the experimental results, when diluted soot nanoparticles (diameter < 150 nm) were employed as delivered entity. An additional simulation study demonstrated a threefold increase in the volume covered by the delivered agent in liver under a constant injection rate, when compared to without US. This method, if developed to its full potential, could serve as a cost effective way to improve safety and efficacy of drug therapies by maximizing the concentration of delivered entities within, e.g., a small lesion, while minimizing exposure outside the lesion.
| Original language | English |
|---|---|
| Pages (from-to) | 251-265 |
| Number of pages | 15 |
| Journal | Journal of the Acoustical Society of America |
| Volume | 152 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 1 Jul 2022 |
| MoE publication type | A1 Journal article-refereed |
Funding
We thank all members of the Medical Ultrasonics Laboratory (MEDUSA) at Aalto University for constructive discussions related to the topic. The Academy of Finland is acknowledged for financial support (Grant Nos. 314286, 311586, and 335799). All authors contributed to the design of the study, writing, or reviewing the manuscript, and have approved the final version of the manuscript. E.P. produced all data and conducted the data analysis. H.J.N. and K.P.H.P. have stock ownership in Swan Cytologics Inc., Toronto, ON, Canada, and are inventors within the patent application WO2018000102A1. H.J.N. is also an inventor within the patent application WO2020240084A1. E.P. and N.H. do not have any competing interests in relation to this work. The datasets are available upon request. The codes are available upon request.
Fingerprint
Dive into the research topics of 'An ultrasonically actuated needle promotes the transport of nanoparticles and fluids'. Together they form a unique fingerprint.Projects
- 3 Finished
-
USeFNB: Ultrasound-enhanced fine-needle biopsy: sound-tissue -interactions
Nieminen, H. (Principal investigator), Ranjan, S. (Project Member), Le Bourlout, Y. (Project Member), Perra, E. (Project Member), Hayward, N. (Project Member), Bunni, S. (Project Member), Nallannan, B. (Project Member) & Rantanen, J. (Project Member)
01/09/2020 → 30/06/2023
Project: Academy of Finland: Other research funding
-
USeFNB: Ultrasound-enhanced fine-needle biopsy: sound-tissue interactions
Nieminen, H. (Principal investigator), Le Bourlout, Y. (Project Member), Rantanen, J. (Project Member), Fauconnier, M. (Project Member), Rehell, M. (Project Member), Ehnholm, G. (Project Member), Kiviluoto, J. (Project Member), Mikkola, M. (Project Member), Perra, E. (Project Member) & Ansari, A. (Project Member)
01/09/2017 → 15/09/2023
Project: Academy of Finland: Other research funding
-
USeFNB: Ultrasound-enhanced fine-needle biopsy (USeFNB): sound-tissue –interactions
Nieminen, H. (Principal investigator), Arif, M. (Project Member), Hayward, N. (Project Member), Nallannan, B. (Project Member) & Perra, E. (Project Member)
01/09/2017 → 30/08/2020
Project: Academy of Finland: Other research funding